A new mass spectrometry system for advanced biomedical research
A dual-source ion mobility mass spectrometry system
This study is creating a new, advanced tool that helps scientists at the University of Illinois Chicago better understand diseases like cancer and brain disorders by allowing them to analyze tiny molecules in detail, making it easier for researchers from different labs to discover important information that could lead to new treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-11102407 on NIH RePORTER |
What this research studies
This research aims to establish a dual-source ion mobility hybrid mass spectrometry system at the University of Illinois Chicago. This advanced instrument will enhance the capabilities of researchers by allowing for high-resolution measurements in various biomedical fields, including cancer research and neurodegeneration. The system will support diverse applications such as proteomics, lipidomics, and metabolomics, enabling researchers to make significant discoveries through improved analytical performance. It will be accessible to a wide range of users, including those from multiple NIH-funded research centers.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals involved in biomedical research, particularly those focusing on cancer, neurodegeneration, and public health.
Not a fit: Patients not engaged in biomedical research or those outside the focus areas of cancer and neurodegeneration may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to groundbreaking discoveries in cancer and other diseases through enhanced analytical techniques.
How similar studies have performed: Other research has successfully utilized advanced mass spectrometry techniques, indicating a strong potential for impactful outcomes in this area.
Where this research is happening
Chicago, UNITED STATES
- University of Illinois at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Cologna, Stephanie M — University of Illinois at Chicago
- Study coordinator: Cologna, Stephanie M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.